| Dr Deana R Brotherton, MD | |
|
653 Merchants Greene Blvd., Suite 201, Morristown, TN 37813 | |
| (423) 492-6700 | |
| (865) 374-2131 |
| Full Name | Dr Deana R Brotherton |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 27 Years |
| Location | 653 Merchants Greene Blvd., Morristown, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508836842 | NPI | - | NPPES |
| 3144182 | Other | TN | BLUECARE-BOGARD |
| 100028814 | Other | TN | PHP |
| 3144180 | Other | TN | BCBST |
| 3144181 | Other | TN | BCBST |
| 3142811 | Other | TN | BCBST |
| 3846342 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD30887 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Morristown Hamblen Hospital Association | Morristown, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Covenant Medical Group Inc | 2860305463 | 282 |
| Volunteer Healthcare Services, Inc. | 8820003981 | 47 |
News Archive
In the May 3 issue of the Journal of the American Medical Association, Brian L. Strom, MD, MPH, Professor of Public Health and Preventive Medicine and Chair of the Department of Biostatistics and Epidemiology at the University of Pennsylvania School of Medicine, analyzes the limitations of the current system of drug-safety monitoring and proposes a solution that addresses overly aggressive early marketing practices
Nova Southeastern University's College of Osteopathic Medicine (NSU-COM) received approval for a new medical specialty—correctional medicine—that was developed at the college in collaboration with the Florida Department of Corrections.
The National Cancer Coalition (NCC) is pleased to announce its recent collaboration with Pfizer, Inc to provide hemophilia medicines to underserved patients in the developing world. To date, NCC has received more than 10 million international units of ReFacto® Antihemophilic Factor (Recombinant), a therapy used for the treatment and prevention of bleeding in people with hemophilia A, to assist patients who otherwise would have little opportunity for adequate treatment. The value of this donation is more than $13 million, and it will help many hundreds of hemophilia patients around the world.
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announces that the multiple ascending dose Phase I study of the novel, first in class calcium channel blocker CNV2197944, for the treatment of chronic pain has been initiated.
› Verified 5 days ago
| Entity Name | Rural Medical Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962443697 PECOS PAC ID: 1456384080 Enrollment ID: O20050914001081 |
News Archive
In the May 3 issue of the Journal of the American Medical Association, Brian L. Strom, MD, MPH, Professor of Public Health and Preventive Medicine and Chair of the Department of Biostatistics and Epidemiology at the University of Pennsylvania School of Medicine, analyzes the limitations of the current system of drug-safety monitoring and proposes a solution that addresses overly aggressive early marketing practices
Nova Southeastern University's College of Osteopathic Medicine (NSU-COM) received approval for a new medical specialty—correctional medicine—that was developed at the college in collaboration with the Florida Department of Corrections.
The National Cancer Coalition (NCC) is pleased to announce its recent collaboration with Pfizer, Inc to provide hemophilia medicines to underserved patients in the developing world. To date, NCC has received more than 10 million international units of ReFacto® Antihemophilic Factor (Recombinant), a therapy used for the treatment and prevention of bleeding in people with hemophilia A, to assist patients who otherwise would have little opportunity for adequate treatment. The value of this donation is more than $13 million, and it will help many hundreds of hemophilia patients around the world.
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announces that the multiple ascending dose Phase I study of the novel, first in class calcium channel blocker CNV2197944, for the treatment of chronic pain has been initiated.
› Verified 5 days ago
| Entity Name | Covenant Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457302010 PECOS PAC ID: 2860305463 Enrollment ID: O20060719000030 |
News Archive
In the May 3 issue of the Journal of the American Medical Association, Brian L. Strom, MD, MPH, Professor of Public Health and Preventive Medicine and Chair of the Department of Biostatistics and Epidemiology at the University of Pennsylvania School of Medicine, analyzes the limitations of the current system of drug-safety monitoring and proposes a solution that addresses overly aggressive early marketing practices
Nova Southeastern University's College of Osteopathic Medicine (NSU-COM) received approval for a new medical specialty—correctional medicine—that was developed at the college in collaboration with the Florida Department of Corrections.
The National Cancer Coalition (NCC) is pleased to announce its recent collaboration with Pfizer, Inc to provide hemophilia medicines to underserved patients in the developing world. To date, NCC has received more than 10 million international units of ReFacto® Antihemophilic Factor (Recombinant), a therapy used for the treatment and prevention of bleeding in people with hemophilia A, to assist patients who otherwise would have little opportunity for adequate treatment. The value of this donation is more than $13 million, and it will help many hundreds of hemophilia patients around the world.
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announces that the multiple ascending dose Phase I study of the novel, first in class calcium channel blocker CNV2197944, for the treatment of chronic pain has been initiated.
› Verified 5 days ago
| Entity Name | Apogee Medical Group Tennessee Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578717682 PECOS PAC ID: 4688721863 Enrollment ID: O20090403000215 |
News Archive
In the May 3 issue of the Journal of the American Medical Association, Brian L. Strom, MD, MPH, Professor of Public Health and Preventive Medicine and Chair of the Department of Biostatistics and Epidemiology at the University of Pennsylvania School of Medicine, analyzes the limitations of the current system of drug-safety monitoring and proposes a solution that addresses overly aggressive early marketing practices
Nova Southeastern University's College of Osteopathic Medicine (NSU-COM) received approval for a new medical specialty—correctional medicine—that was developed at the college in collaboration with the Florida Department of Corrections.
The National Cancer Coalition (NCC) is pleased to announce its recent collaboration with Pfizer, Inc to provide hemophilia medicines to underserved patients in the developing world. To date, NCC has received more than 10 million international units of ReFacto® Antihemophilic Factor (Recombinant), a therapy used for the treatment and prevention of bleeding in people with hemophilia A, to assist patients who otherwise would have little opportunity for adequate treatment. The value of this donation is more than $13 million, and it will help many hundreds of hemophilia patients around the world.
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announces that the multiple ascending dose Phase I study of the novel, first in class calcium channel blocker CNV2197944, for the treatment of chronic pain has been initiated.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Deana R Brotherton, MD 653 Merchants Greene Blvd., Suite 201, Morristown, TN 37813 Ph: (423) 492-6700 | Dr Deana R Brotherton, MD 653 Merchants Greene Blvd., Suite 201, Morristown, TN 37813 Ph: (423) 492-6700 |
News Archive
In the May 3 issue of the Journal of the American Medical Association, Brian L. Strom, MD, MPH, Professor of Public Health and Preventive Medicine and Chair of the Department of Biostatistics and Epidemiology at the University of Pennsylvania School of Medicine, analyzes the limitations of the current system of drug-safety monitoring and proposes a solution that addresses overly aggressive early marketing practices
Nova Southeastern University's College of Osteopathic Medicine (NSU-COM) received approval for a new medical specialty—correctional medicine—that was developed at the college in collaboration with the Florida Department of Corrections.
The National Cancer Coalition (NCC) is pleased to announce its recent collaboration with Pfizer, Inc to provide hemophilia medicines to underserved patients in the developing world. To date, NCC has received more than 10 million international units of ReFacto® Antihemophilic Factor (Recombinant), a therapy used for the treatment and prevention of bleeding in people with hemophilia A, to assist patients who otherwise would have little opportunity for adequate treatment. The value of this donation is more than $13 million, and it will help many hundreds of hemophilia patients around the world.
Convergence Pharmaceuticals Limited, the company focused on the development of novel and high value analgesic medicines, today announces that the multiple ascending dose Phase I study of the novel, first in class calcium channel blocker CNV2197944, for the treatment of chronic pain has been initiated.
› Verified 5 days ago
David A Johnson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 500 Mcfarland Street, Healthstar Physicians, Morristown, TN 37814 Phone: 423-587-5551 Fax: 423-587-0347 | |
Dr. Kevin Guy Catney, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4845 West Andrew Johnson Highway, Morristown, TN 37814 Phone: 423-839-1200 Fax: 423-839-1250 | |
Dr. Harry Allie Zain, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 230 Bowman St, Suite B, Morristown, TN 37813 Phone: 423-586-1356 Fax: 423-585-5613 | |
Danielle J Darter, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Boyd School Rd, Morristown, TN 37813 Phone: 423-587-3407 Fax: 423-587-3405 | |
Dr. Karen L Harsh, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 305 N Bellwood Rd, Morristown, TN 37814 Phone: 423-587-8300 Fax: 423-587-6500 | |
Dr. Rajeev Gupta, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1621 W Morris Blvd Ste C, Morristown, TN 37813 Phone: 423-317-7412 Fax: 423-317-7415 | |
Shannon Paul Hancock, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4138 Durham Lndg, Morristown, TN 37813 Phone: 423-586-1717 Fax: 423-586-1763 |